Influenza Antigen Articles & Analysis: Older
4 articles found
In contrast to the dominance of new technologies in HIV vaccine development, 40% of influenza vaccine candidates are inactivated. Given the wide variety of influenza subtypes resulting from antigenic drift, universal vaccines are increasingly being developed to reduce the need for frequent vaccinations. These vaccines are designed based on highly ...
Virus infection and transmission endanger human health and socio-economic development. Influenza is a respiratory infection caused by the influenza virus. Influenza viruses are antigenically variable, spread rapidly, and can cause seasonal epidemics each year. ...
This safety profile, M2SR’s ability to induce a strong immune response, and the ability of influenza viruses to carry sequences of other viruses make M2SR an attractive option for rapidly developing CoroFlu as a safe and effective SARS-CoV-2 vaccine. ...
There are two antigenically distinct lineages of influenza B virus, Yamagata lineage (YL) and Victoria lineage (VL). Since both B lineages have been co-circulating for years, more than 70% of influenza vaccines currently manufactured are quadrivalent consisting of influenza A (H1N1), influenza A (H3N2), ...